DE602005007763D1 - Verfahren zur herstellung eines enantiomers von amlodipin in hoher optischer reinheit - Google Patents

Verfahren zur herstellung eines enantiomers von amlodipin in hoher optischer reinheit

Info

Publication number
DE602005007763D1
DE602005007763D1 DE602005007763T DE602005007763T DE602005007763D1 DE 602005007763 D1 DE602005007763 D1 DE 602005007763D1 DE 602005007763 T DE602005007763 T DE 602005007763T DE 602005007763 T DE602005007763 T DE 602005007763T DE 602005007763 D1 DE602005007763 D1 DE 602005007763D1
Authority
DE
Germany
Prior art keywords
amlodipin
enantiomer
preparing
optical purity
highly optical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005007763T
Other languages
English (en)
Inventor
Milind Moreshwar Gharpure
Baburao Manikrao Bhawal
Prasad Vasudeo Ranade
Rajendra Dagadu Deshmukh
Satish Ramanlal Mehta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emcure Pharmaceuticals Ltd
Original Assignee
Emcure Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emcure Pharmaceuticals Ltd filed Critical Emcure Pharmaceuticals Ltd
Publication of DE602005007763D1 publication Critical patent/DE602005007763D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE602005007763T 2004-10-20 2005-10-17 Verfahren zur herstellung eines enantiomers von amlodipin in hoher optischer reinheit Active DE602005007763D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1123MU2004 2004-10-20
PCT/IB2005/003108 WO2006043148A1 (en) 2004-10-20 2005-10-17 Process for producing enantiomer of amlodipine in high optical purity

Publications (1)

Publication Number Publication Date
DE602005007763D1 true DE602005007763D1 (de) 2008-08-07

Family

ID=35708803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005007763T Active DE602005007763D1 (de) 2004-10-20 2005-10-17 Verfahren zur herstellung eines enantiomers von amlodipin in hoher optischer reinheit

Country Status (11)

Country Link
US (2) US7858801B2 (de)
EP (1) EP1802576B1 (de)
JP (1) JP4932728B2 (de)
KR (1) KR101130622B1 (de)
AT (1) ATE399154T1 (de)
BR (1) BRPI0511095B8 (de)
DE (1) DE602005007763D1 (de)
ES (1) ES2307209T3 (de)
PT (1) PT1802576E (de)
RU (1) RU2376288C2 (de)
WO (1) WO2006043148A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0500570A3 (en) * 2005-06-08 2008-03-28 Richter Gedeon Nyrt Process for the preparation of (s)-(-)-amlodipine
KR100913791B1 (ko) * 2006-07-21 2009-08-26 한미약품 주식회사 (s)-(-)-암로디핀 캠실레이트 또는 이의 수화물 및 이를함유하는 약학적 조성물
WO2008026838A1 (en) * 2006-08-30 2008-03-06 Chemtech Research Incorporation Method for preparing an optically active amlodipine
KR100828883B1 (ko) * 2006-10-27 2008-05-09 씨제이제일제당 (주) 라세믹 암로디핀으로부터 s-(-)-암로디핀의 분리방법
CN101773500B (zh) * 2010-02-09 2012-05-23 施慧达药业集团(吉林)有限公司 抗高血压的药物组合物
CN101766611B (zh) * 2010-02-09 2011-10-12 施慧达药业集团(吉林)有限公司 一种左旋氨氯地平或其可药用盐和β受体阻滞剂的药物组合物及其应用
KR101313842B1 (ko) * 2010-09-15 2013-10-01 대화제약 주식회사 에스-암로디핀 베실레이트 및 그 수화물의 제조방법
CN111689894B (zh) * 2019-03-13 2023-05-02 鲁南制药集团股份有限公司 一种苯磺酸左旋氨氯地平晶型
CN112110850B (zh) * 2019-06-20 2023-05-02 鲁南制药集团股份有限公司 一种苯磺酸左旋氨氯地平新晶型
CN110882249B (zh) 2019-11-08 2021-04-30 北京吾为尔创科技有限公司 含苯磺酸左氨氯地平水合物的组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804630D0 (en) 1988-02-27 1988-03-30 Pfizer Ltd Preparation of r-& s-amlodipine
EP1013275A3 (de) * 1991-11-26 2001-01-10 Sepracor, Inc. Verfahren und Zusammensetzungen zur behandlung von Bluthochdruck, Angina und anderen Erkrankungen mit optisch Reinem(-) Amlodipin
US6057344A (en) 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
GB9317773D0 (en) 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
CN1100038C (zh) 2000-02-21 2003-01-29 张喜田 氨氯地平对映体的拆分
NZ532316A (en) 2001-10-24 2005-10-28 Sepracor Inc Method of resolving amlodipine racemate
US20030176706A1 (en) 2002-03-18 2003-09-18 Joshi Rohini Ramesh Process for the preparation of [S(-) amlodipine - L (+)- hemitartarate]
EP1348697A1 (de) 2002-03-28 2003-10-01 Council Of Scientific & Industrial Research Verfahren zur Herstellung von S(-)-amlodipine-L(+)-hemitartrate
KR100476636B1 (ko) 2002-09-11 2005-03-17 한림제약(주) 엘-(+)-타르트레이트를 이용한 에스-(-)-암로디핀의 제조방법
EP1407773A1 (de) 2002-10-08 2004-04-14 Council of Scientific and Industrial Research Verfahren zur Herstellung von s(-)Amlodipin-Salzen
US6608206B1 (en) * 2002-10-30 2003-08-19 Council Of Scientific & Industrial Research Process for making S(-) Amlodipine salts
EP1687273A1 (de) * 2003-11-20 2006-08-09 Council Of Scientific And Industrial Research Verfahren zur herstellung chiraler amlodipinsalze

Also Published As

Publication number Publication date
US20080262239A1 (en) 2008-10-23
BRPI0511095A (pt) 2007-12-26
US8445688B2 (en) 2013-05-21
ATE399154T1 (de) 2008-07-15
ES2307209T3 (es) 2008-11-16
PT1802576E (pt) 2008-09-15
RU2006138705A (ru) 2008-05-10
EP1802576A1 (de) 2007-07-04
BRPI0511095B8 (pt) 2021-05-25
JP4932728B2 (ja) 2012-05-16
US7858801B2 (en) 2010-12-28
KR20070062946A (ko) 2007-06-18
WO2006043148A1 (en) 2006-04-27
EP1802576B1 (de) 2008-06-25
BRPI0511095B1 (pt) 2021-01-19
WO2006043148B1 (en) 2006-06-08
JP2008517050A (ja) 2008-05-22
KR101130622B1 (ko) 2012-04-02
RU2376288C2 (ru) 2009-12-20
US20110021783A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
DE602005007763D1 (de) Verfahren zur herstellung eines enantiomers von amlodipin in hoher optischer reinheit
ATE417036T1 (de) Verbessertes verfahren zur herstellung von 3- hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen
DE502005003669D1 (de) Verfahren zur herstellung von emulsionen von hochviskosen organopolysiloxanen
DE60321625D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60138141D1 (de) Photosensibilisator und verfahren zu seiner herstellung
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
DE602004027229D1 (de) Verfahren zur herstellung von photonischer kristallfaser
DE602005026827D1 (de) Verfahren zur herstellung von isoindolderivaten
ATE445601T1 (de) Verfahren zur herstellung von carvedilol und seinen enantiomeren
ATE485273T1 (de) Verfahren zur optischen auftrennung von amlodipin
ATE470654T1 (de) Verfahren zur herstellung von fluorierten estern, fluoriertem acylfluorid und fluorierten vinylethern
DE502005007103D1 (de) Verfahren zur herstellung der enantiomeren formen von cis-3-hydroxycyclohexancarbonsäure-derivaten unter verwendung von hydrolasen
ATE365459T1 (de) Verfahren zur herstellung von hochwertigen fermentierten sojabohnenprodukten
DE60321626D1 (de) Verfahren zur Herstellung von Acrylsäure
DE102004048741B8 (de) Verfahren zur Herstellung eines Lichtleitfaserabschlusses
DE50207455D1 (de) Verfahren ZUR HERSTELLUNG VON CARBONSÄURESALZEN
DE602004021605D1 (de) Verfahren zur herstellung von enantiomerenreinem mirtazapin
DE60126744D1 (de) Verfahren zur herstellung von 2-hydroxy-4-methylthio-buttersäure-estern
DE60012491D1 (de) Verfahren zur herstellung von hydroxymethylbuttersäureestern
DE50111897D1 (de) VERFAHREN ZUR HERSTELLUNG VON ESTERN alpha, beta -UNGESÄTTIGTER CARBONSÄUREN
ATE428707T1 (de) Verfahren zur herstellung des (s)-enantiomers von omeprazol
ATE290099T1 (de) Verfahren zur herstellung optisch aktiver amine
DE602004019523D1 (de) Verfahren zur herstellung von optisch aktivem chroman-carbonsäureester
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
ATE499449T1 (de) Verfahren zur herstellung optisch aktiver (s)- oder (r)-beta -aminosäuren und optisch aktiver (r)- oder (s)-beta -aminosäureester, und optisch aktive (s)- oder (r)-2-alkoxyethylester von beta- aminosäuren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition